Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 4993 Records) |
Query Trace: Neoplasms and EGFR[original query] |
---|
Monitoring ctDNA RAS Mutational Status in Metastatic Colorectal Cancer: A Trial Protocol of RAS-trace and RAS-trace-2 Studies. Journal of the anus, rectum and colon 2024 5 8 (2): 132-136. Kozo Kataoka, Takeshi Yamada, Manabu Shiozawa, Naoto Takase, Kazuma Ito, Kentaro Yamazaki, Jun Watanabe, Toshihiro Kudo, Takeshi Suto, Toshihiko Matsumoto, Kohei Murata, Yusuke Suwa, Shogen Boku, Hisateru Yasui, Nobuhisa Matsuhashi, Atsuyuki Maeda, Kiichi Sugimoto, Yusuke Matsumoto, Mitsuru Yokota, Johannes Fredebohm, Keita Mori, Masataka Ike |
Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer. Cancer discovery 2024 4 OF1-OF12. Rona Yaeger, Nataliya V Uboha, Meredith S Pelster, Tanios S Bekaii-Saab, Minal Barve, Joel Saltzman, Joshua K Sabari, Julio A Peguero, Andrew Scott Paulson, Pasi A Jänne, Marcia Cruz-Correa, Kenna Anderes, Karen Velastegui, Xiaohong Yan, Hirak Der-Torossian, Samuel J Klempner, Scott E Kope |
The impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non-small cell lung cancer: A meta-analysis. The clinical respiratory journal 2024 4 18 (4): e13748. Liuxian Guo, Guojin Zhou, Min Huang, Kejing Tang, Jing Xu, Jie Ch |
Genomic ancestry and cancer among Latin Americans. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 4 . Alejandro Ruíz-Patiño, Leonardo Rojas, Jairo Zuluaga, Oscar Arrieta, Luis Corrales, Claudio Martín, Sandra Franco, Luis Raez, Christian Rolfo, Natalia Sánchez, Andrés Felipe Cardo |
Lung Cancer Clinical Trials in Latin America in the Era of Cooperative Groups: A 20-Year Analysis. JCO global oncology 2024 4 10 e2300379. Thomas Knapp, Joseph Nygaard, Joshua Cassinat, Fernando Galvez, Priya K Gopal |
The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2. PloS one 2024 4 19 (4): e0301120. Man-San Zhang, Yi-Chen Yeh, Hsien-Neng Huang, Long-Wei Lin, Yen-Lin Huang, Lei-Chi Wang, Lai-Jin Yao, Tze-Chun Hung, Yu-Fen Tseng, Yi-Hsuan Lee, Wei-Yu Liao, Jin-Yuan Shih, Min-Shu Hsi |
Prognostic importance of prognostic nutritional index and modified Glasgow prognostic score in advanced lung cancer with targetable mutation. Journal of cancer research and clinical oncology 2024 4 150 (4): 215. Burak Bilgin, Yunus Kuralay, Sebnem Yuc |
Prognostic implications of combining EGFR-TKIs and radiotherapy in Stage IV lung adenocarcinoma with 19-Del or 21-L858R mutations: A real-world study. Cancer medicine 2024 4 13 (8): e7208. Shuai Liang, Hanyu Wang, Yingyun Zhang, Haixia Tian, Chengming Li, Dong H |
Lung adenocarcinoma with EGFR L858R-K860I and L858R-L861F doublet mutations from which the L858R mutation is undetectable through the cobas EGFR mutation test v2. Pathology, research and practice 2024 4 257 155304. Chi-Hsuan Wu, Man-San Zhang, Yen-Lin Huang, Wei-Hsiang Cheng, Jin-Yao Lai, Min-Shu Hsieh, Wei-Yu Li |
Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer. Frontiers in pharmacology 2024 4 15 1331138. Xiaojuan Zhang, Mina Zhang, Xinyang Du, Guowei Zhang, Yuanyuan Niu, Chunhua Wei, Lanwei Guo, Chao Shi, Hangfan Liu, Huijuan Wa |
Genomic landscape of diploid and aneuploid microsatellite stable early onset colorectal cancer. Scientific reports 2024 4 14 (1): 9368. Yumei Zhou, Xianfeng Chen, Jun Chen, Conner D Kendrick, Ramesh K Ramanathan, Rondell P Graham, Kimberlee F Kossick, Lisa A Boardman, Michael T Barre |
A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer. Frontiers in oncology 2024 4 14 1314301. Song Hu, Hao Ming, Qian He, Ming Ding, Hao Ding, Chong |
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer. Journal of translational medicine 2024 4 22 (1): 326. Wei-Chi Luo, Shi-Qi Mei, Zi-Jian Huang, Zhi-Hong Chen, Yi-Chen Zhang, Ming-Yi Yang, Jia-Qi Liu, Jing-Yan Xu, Xiao-Rong Yang, Ri-Wei Zhong, Li-Bo Tang, Lin-Xi Yin, Yu Deng, Ying-Long Peng, Chang Lu, Bao-Long Chen, Dong-Xian Ke, Hai-Yan Tu, Jin-Ji Yang, Chong-Rui Xu, Yi-Long Wu, Qing Zh |
MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting? Lung Cancer (Auckland, N.Z.) 2024 4 15 41-47. Danielle Brazel, Misako Nagasa |
Incidental detection of ground glass nodules and primary lung cancer in patients with breast cancer: prevalence and long-term follow-up on chest computed tomography. Journal of thoracic disease 2024 4 16 (3): 1804-1814. Hye Sun Ryu, Han Na Lee, Jung Im Kim, Jung Kyu Ryu, Yu Jin L |
Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer. Lung cancer (Amsterdam, Netherlands) 2024 4 191 107540. Takehiro Tozuka, Rintaro Noro, Hideaki Mizutani, Futoshi Kurimoto, Taiki Hakozaki, Kakeru Hisakane, Tomoyuki Naito, Satoshi Takahashi, Namiko Taniuchi, Chika Yajima, Yukio Hosomi, Takashi Hirose, Yuji Minegishi, Tetsuya Okano, Koichiro Kamio, Tomoyoshi Yamaguchi, Masahiro Seike, |
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101). Targeted oncology 2024 4 . Naoya Nishioka, Hisao Imai, Masahiro Endo, Akifumi Notsu, Kosei Doshita, Satoshi Igawa, Hiroshi Yokouchi, Takashi Ninomiya, Takaaki Tokito, Sayo Soda, Takasato Fujiwara, Tetsuhiko Asao, Shinji Nakamichi, Takahisa Kawamura, Minehiko Inomata, Kazuhisa Nakashima, Kentaro Ito, Yasuhiro Goto, Yukihiro Umeda, Soichi Hirai, Ryota Ushio, Keiki Yokoo, Takayuki Takeda, Tomoya Fukui, Masashi Ishihara, Takashi Osaki, Sousuke Kubo, Takumi Fujiwara, Chie Yamamoto, Takeshi Tsuda, Nobumasa Tamura, Shinobu Hosokawa, Yusuke Chihara, Satoshi Ikeda, Naoki Furuya, Yoshiro Nakahara, Satoru Miura, Hiroaki Okamo |
Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive Cohort. Cancers 2024 4 16 (7): . Rossella Bruno, Anello Marcello Poma, Martina Panozzi, Alessandra Lenzini, Gianmarco Elia, Carmelina Cristina Zirafa, Vittorio Aprile, Marcello Carlo Ambrogi, Editta Baldini, Marco Lucchi, Franca Melfi, Antonio Chella, Andrea Sbrana, Greta A |
Uncommon and Rare EGFR Mutations in Non-Small Cell Lung Cancer Patients with a Focus on Exon 20 Insertions and the Phase 3 PAPILLON Trial: The State of the Art. Cancers 2024 4 16 (7): . Federico Pio Fabrizio, Ilaria Attili, Filippo de Marin |
Case report: Efficacy of icotinib treatment in lung adenocarcinoma with esophageal squamous cell carcinoma: a rare case of double primary malignant tumors. Frontiers in medicine 2024 4 11 1266062. Min Deng, Xiaoqing Li, Honghao Mu, Man Wei, Lan S |
Habitat-Based Radiomics for Predicting EGFR Mutations in Exon 19 and 21 From Brain Metastasis. Academic radiology 2024 4 . Chunna Yang, Ying Fan, Dan Zhao, Zekun Wang, Xiaoyu Wang, Huan Wang, Yanjun Hu, Lingzi He, Jin Zhang, Yan Wang, Yan Liu, Xianzheng Sha, Juan |
Combining genomic biomarkers to guide immunotherapy in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 2 . Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert F Smit, Lodewyk F A Wessels, Edwin Cuppen, Joachim G J V Aerts, Emile E Voe |
Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer; Single-Institution Experience. Cancer research and treatment 2024 1 . So Heun Lee, Hyehyun Jeong, Deok Hoon Kim, Se Jin Jang, Sang-We Kim, Shinkyo Yoon, Dae Ho L |
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101). Cancer science 2024 1 . Kosuke Tsuji, Hidenori Mizugaki, Keiki Yokoo, Maki Kobayashi, Yosuke Kawashima, Nozomu Kimura, Hiroshi Yokouchi, Hajime Kikuchi, Toshiyuki Sumi, Yasutaka Kawai, Kenta Kobashi, Ryo Morita, Kenichiro Ito, Yasuo Kitamura, Hiroyuki Minemura, Keiichi Nakamura, Mari Aso, Osamu Honjo, Hisashi Tanaka, Taichi Takashina, Kyoji Tsurumi, Jun Sugisaka, Yoko Tsukita, Satoshi Konno, Satoshi Oizu |
PD-L1 expression and its significance in advanced NSCLC: real-world experience from a tertiary care center. Journal of the Egyptian National Cancer Institute 2024 1 36 (1): 3. Sindhu Kilaru, Soumya Surath Panda, Lalatendu Moharana, Debahuti Mohapatra, Satya Sundar G Mohapatra, Adyakinkar Panda, Spoorthy Kolluri, Suma Devaraj, Ghanashyam Bisw |
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors. The journal of pathology. Clinical research 2024 1 10 (2): e354. Michael Menzel, Martina Kirchner, Klaus Kluck, Markus Ball, Susanne Beck, Michael Allgäuer, Christin Assmann, Johannes Schnorbach, Anna-Lena Volckmar, Timothy Kwang Yong Tay, Hannah Goldschmid, Daniel Sw Tan, Michael Thomas, Daniel Kazdal, Jan Budczies, Albrecht Stenzinger, Petros Christopoul |
QL1706 (anti-PD-1 IgG4/CTLA-4 antibody) plus chemotherapy with or without bevacizumab in advanced non-small cell lung cancer: a multi-cohort, phase II study. Signal transduction and targeted therapy 2024 1 9 (1): 23. Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Hongyun Zhao, Ningning Zhou, Yaxiong Zhang, Likun Chen, Ting Zhou, Gang Chen, Ting Wu, Lu Lu, Shilin Xue, Xiaoyan Kang, Li Zhang, Wenfeng Fa |
Efficacy and safety of 40?mg osimertinib administered every other day for non-small cell lung cancer harboring an epidermal growth factor receptor mutation: A single-center retrospective cohort study. Thoracic cancer 2024 1 . Ayumu Otsuki, Naoki Inoshima, Kentaro Tochigi, Hiroyuki Ito, Kei Nakashi |
Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer. Thoracic cancer 2024 1 . Li-Chung Chiu, Ping-Chih Hsu, Chin-Chou Wang, How-Wen Ko, Scott Chih-Hsi Kuo, Jia-Shiuan Ju, Pi-Hung Tung, Allen Chung-Cheng Huang, Cheng-Ta Ya |
GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning. Scientific reports 2024 1 14 (1): 2126. Shuhua Zheng, Nikhil Rammohan, Timothy Sita, P Troy Teo, Yilin Wu, Maciej Lesniak, Sean Sachdev, Tarita O Thom |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: